GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vincent Medical Holdings Ltd (HKSE:01612) » Definitions » Intrinsic Value: Projected FCF

Vincent Medical Holdings (HKSE:01612) Intrinsic Value: Projected FCF : HK$1.59 (As of Jun. 22, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vincent Medical Holdings Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-06-22), Vincent Medical Holdings's Intrinsic Value: Projected FCF is HK$1.59. The stock price of Vincent Medical Holdings is HK$0.43. Therefore, Vincent Medical Holdings's Price-to-Intrinsic-Value-Projected-FCF of today is 0.3.

The historical rank and industry rank for Vincent Medical Holdings's Intrinsic Value: Projected FCF or its related term are showing as below:

HKSE:01612' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.24   Med: 0.8   Max: 1.53
Current: 0.27

During the past 11 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Vincent Medical Holdings was 1.53. The lowest was 0.24. And the median was 0.80.

HKSE:01612's Price-to-Projected-FCF is ranked better than
96.33% of 354 companies
in the Medical Devices & Instruments industry
Industry Median: 1.63 vs HKSE:01612: 0.27

Vincent Medical Holdings Intrinsic Value: Projected FCF Historical Data

The historical data trend for Vincent Medical Holdings's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vincent Medical Holdings Intrinsic Value: Projected FCF Chart

Vincent Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.59 1.18 1.39 1.29 1.59

Vincent Medical Holdings Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.39 - 1.29 - 1.59

Competitive Comparison of Vincent Medical Holdings's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Vincent Medical Holdings's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vincent Medical Holdings's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vincent Medical Holdings's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Vincent Medical Holdings's Price-to-Projected-FCF falls into.



Vincent Medical Holdings Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Vincent Medical Holdings's Free Cash Flow(6 year avg) = HK$45.57.

Vincent Medical Holdings's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Dec23)*0.8)/Shares Outstanding (Diluted Average)
=(12.95911409947*45.574857142857+541.843*0.8)/645.661
=1.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vincent Medical Holdings  (HKSE:01612) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Vincent Medical Holdings's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.43/1.5861019540925
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vincent Medical Holdings Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Vincent Medical Holdings's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Vincent Medical Holdings (HKSE:01612) Business Description

Traded in Other Exchanges
N/A
Address
22 Tak Fung Street, Units 1604-07A, 16th Floor, Two Harbourfront, Hung Hom, Kowloon, Hong Kong, HKG
Vincent Medical Holdings Ltd is an investment holding company engaged in the manufacturing and selling of medical devices. The company operates in two segments: OEM (original equipment manufacturing) and OBM (original brand manufacturing). The OEM segment manufactures products as per the customer requirement. The OBM segment includes research, development, manufacturing, marketing, and sales of medical devices under Inspired Medical, Hand of Hope, and Hypnus brands. Its product categories include Respiratory products, Imaging disposable products, Orthopaedic and rehabilitation products, and Others. Its geographical segments are United States, The PRC, Japan, Costa Rica, The Netherlands, Spain, Germany, Hong Kong, Turkey, Canada, India, Thailand, Vietnam and Others.
Executives
Choi Man Shing 2101 Beneficial owner
Liu Pui Ching 2202 Interest of your spouse
Vincent Raya International Limited

Vincent Medical Holdings (HKSE:01612) Headlines

No Headlines